In Alzheimer’s disease, increased AGEs have been shown to modify tau proteins resulting in increased tauopathies and contributing to the neurodegenerative pathologies of Alzheimer’s disease (Kontaxi et al., 2017). The gene discussed is MAPT; the disease is tauopathy.